NL1007706C2 - Nieuwe formulering. - Google Patents

Nieuwe formulering. Download PDF

Info

Publication number
NL1007706C2
NL1007706C2 NL1007706A NL1007706A NL1007706C2 NL 1007706 C2 NL1007706 C2 NL 1007706C2 NL 1007706 A NL1007706 A NL 1007706A NL 1007706 A NL1007706 A NL 1007706A NL 1007706 C2 NL1007706 C2 NL 1007706C2
Authority
NL
Netherlands
Prior art keywords
budesonide
unit dose
formulation
dose
metered
Prior art date
Application number
NL1007706A
Other languages
English (en)
Dutch (nl)
Other versions
NL1007706A1 (nl
Inventor
Hans Nilsson
Gordon Santesson
Original Assignee
Astra Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26662810&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NL1007706(C2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from SE9604486A external-priority patent/SE9604486D0/xx
Application filed by Astra Ab filed Critical Astra Ab
Publication of NL1007706A1 publication Critical patent/NL1007706A1/xx
Application granted granted Critical
Publication of NL1007706C2 publication Critical patent/NL1007706C2/nl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0043—Nose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/02—Nasal agents, e.g. decongestants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Pulmonology (AREA)
  • Otolaryngology (AREA)
  • Immunology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Compounds Of Unknown Constitution (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines Containing Plant Substances (AREA)
NL1007706A 1996-12-05 1997-12-05 Nieuwe formulering. NL1007706C2 (nl)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
SE9604486A SE9604486D0 (sv) 1996-12-05 1996-12-05 Novel formulation
SE9604486 1996-12-05
US84696097 1997-04-29
US08/846,960 US6291445B1 (en) 1996-12-05 1997-04-29 Low dose budesonide formulations and uses thereof

Publications (2)

Publication Number Publication Date
NL1007706A1 NL1007706A1 (nl) 1998-06-08
NL1007706C2 true NL1007706C2 (nl) 1998-09-22

Family

ID=26662810

Family Applications (1)

Application Number Title Priority Date Filing Date
NL1007706A NL1007706C2 (nl) 1996-12-05 1997-12-05 Nieuwe formulering.

Country Status (23)

Country Link
US (2) US6686346B2 (fr)
EP (1) EP0907365B1 (fr)
JP (1) JP2000508675A (fr)
CN (1) CN1168450C (fr)
AT (2) ATE239482T1 (fr)
AU (1) AU726515B2 (fr)
BE (1) BE1011394A5 (fr)
CZ (1) CZ295792B6 (fr)
DE (2) DE69738000T2 (fr)
DK (1) DK0907365T3 (fr)
ES (1) ES2133130B1 (fr)
FR (1) FR2756739B1 (fr)
GR (1) GR1003011B (fr)
HK (1) HK1020522A1 (fr)
HU (1) HUP0000575A3 (fr)
IE (1) IE970854A1 (fr)
IL (1) IL125534A (fr)
NL (1) NL1007706C2 (fr)
NO (1) NO983555D0 (fr)
NZ (1) NZ330925A (fr)
PT (1) PT907365E (fr)
TR (1) TR199801501T1 (fr)
WO (1) WO1998024450A1 (fr)

Families Citing this family (42)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2756739B1 (fr) * 1996-12-05 2000-04-28 Astra Ab Nouvelle formulation de budesonide
MY133181A (en) * 1998-09-10 2007-10-31 Schering Corp Methods and compositions for treating sinusitis, otitis media and other related disorders using antihistamines
ES2165768B1 (es) 1999-07-14 2003-04-01 Almirall Prodesfarma Sa Nuevos derivados de quinuclidina y composiciones farmaceuticas que los contienen.
AR026073A1 (es) 1999-10-20 2002-12-26 Nycomed Gmbh Composicion farmaceutica acuosa que contiene ciclesonida
US9700866B2 (en) 2000-12-22 2017-07-11 Baxter International Inc. Surfactant systems for delivery of organic compounds
US20030055026A1 (en) * 2001-04-17 2003-03-20 Dey L.P. Formoterol/steroid bronchodilating compositions and methods of use thereof
BR0212833A (pt) 2001-09-26 2004-10-13 Baxter Int Preparação de nanopartìculas de tamanho submìcron através de dispersão e de remoção de solvente ou de fase lìquida
US7112340B2 (en) * 2001-10-19 2006-09-26 Baxter International Inc. Compositions of and method for preparing stable particles in a frozen aqueous matrix
GB2389530B (en) 2002-06-14 2007-01-10 Cipla Ltd Pharmaceutical compositions
US9808471B2 (en) * 2003-04-16 2017-11-07 Mylan Specialty Lp Nasal pharmaceutical formulations and methods of using the same
US7811606B2 (en) 2003-04-16 2010-10-12 Dey, L.P. Nasal pharmaceutical formulations and methods of using the same
US8912174B2 (en) 2003-04-16 2014-12-16 Mylan Pharmaceuticals Inc. Formulations and methods for treating rhinosinusitis
TWI359675B (en) 2003-07-10 2012-03-11 Dey L P Bronchodilating β-agonist compositions
US20050026887A1 (en) * 2003-07-29 2005-02-03 Boehringer Ingelheim International Gmbh Medicaments for inhalation comprising an anticholinergic and a steroid
WO2005027853A2 (fr) * 2003-09-19 2005-03-31 University Of Louisville Research Foundation Inc Methode de traitement du ronflement et de l'apnee du sommeil avec des antagonistes de la leucotriene
US20070020299A1 (en) 2003-12-31 2007-01-25 Pipkin James D Inhalant formulation containing sulfoalkyl ether cyclodextrin and corticosteroid
US20070020298A1 (en) * 2003-12-31 2007-01-25 Pipkin James D Inhalant formulation containing sulfoalkyl ether gamma-cyclodextrin and corticosteroid
US8679545B2 (en) 2005-11-12 2014-03-25 The Regents Of The University Of California Topical corticosteroids for the treatment of inflammatory diseases of the gastrointestinal tract
US8497258B2 (en) 2005-11-12 2013-07-30 The Regents Of The University Of California Viscous budesonide for the treatment of inflammatory diseases of the gastrointestinal tract
US8324192B2 (en) 2005-11-12 2012-12-04 The Regents Of The University Of California Viscous budesonide for the treatment of inflammatory diseases of the gastrointestinal tract
US20070110788A1 (en) * 2005-11-14 2007-05-17 Hissong James B Injectable formulation capable of forming a drug-releasing device
US7959943B2 (en) * 2006-05-10 2011-06-14 Medtronics Xomed, Inc. Solvating system and sealant for medical use in the middle or inner ear
US20070264296A1 (en) * 2006-05-10 2007-11-15 Myntti Matthew F Biofilm extracellular polysachharide solvating system
US7993675B2 (en) * 2006-05-10 2011-08-09 Medtronic Xomed, Inc. Solvating system and sealant for medical use in the sinuses and nasal passages
US7976873B2 (en) * 2006-05-10 2011-07-12 Medtronic Xomed, Inc. Extracellular polysaccharide solvating system for treatment of bacterial ear conditions
ES2298049B1 (es) * 2006-07-21 2009-10-20 Laboratorios Almirall S.A. Procedimiento para fabricar bromuro de 3(r)-(2-hidroxi-2,2-ditien-2-ilacetoxi)-1-(3-fenoxipropil)-1-azoniabiciclo (2.2.2) octano.
US8088095B2 (en) * 2007-02-08 2012-01-03 Medtronic Xomed, Inc. Polymeric sealant for medical use
ES2493641T3 (es) * 2007-06-28 2014-09-12 Cydex Pharmaceuticals, Inc. Administración nasal de soluciones acuosas de corticosteroides
CA2608561A1 (fr) * 2007-10-29 2009-04-29 Carl Paluszkiewicz Support d'accessoires de deflecteur pour motocyclette
US8865692B2 (en) * 2007-11-13 2014-10-21 Meritage Pharma, Inc Compositions for the treatment of gastrointestinal inflammation
US20090123551A1 (en) * 2007-11-13 2009-05-14 Meritage Pharma, Inc. Gastrointestinal delivery systems
US20100216754A1 (en) * 2007-11-13 2010-08-26 Meritage Pharma, Inc. Compositions for the treatment of inflammation of the gastrointestinal tract
CA2704946C (fr) 2007-11-13 2013-09-24 Meritage Pharma, Inc. Compositions pour le traitement de l'inflammation des voies gastro-intestinales
EP2100599A1 (fr) 2008-03-13 2009-09-16 Laboratorios Almirall, S.A. Composition à inhaler comprenant aclidinium pour le traitement de l'asthme et de maladies respiratoires obstructives chroniques
EP2100598A1 (fr) * 2008-03-13 2009-09-16 Laboratorios Almirall, S.A. Composition à inhaler comprenant aclidinium pour le traitement de l'asthme et de maladies respiratoires obstructives chroniques
US20090264392A1 (en) * 2008-04-21 2009-10-22 Meritage Pharma, Inc. Treating eosinophilic esophagitis
EP2303254B1 (fr) 2008-06-12 2019-10-30 Medtronic Xomed, Inc. Produit pour le traitement de plaies chroniques avec un système extracellulaire de solvant comprenant une substance polymérique
WO2010042427A2 (fr) 2008-10-06 2010-04-15 Microbial Defense Systems, Llc Composition antimicrobienne et ses procédés de fabrication et d'utilisation
US20110097401A1 (en) * 2009-06-12 2011-04-28 Meritage Pharma, Inc. Methods for treating gastrointestinal disorders
EP2510928A1 (fr) 2011-04-15 2012-10-17 Almirall, S.A. Aclidinium pour l'amélioration du sommeil des patients avec des maldadies respiratoires
BR112013028673B1 (pt) 2011-05-10 2020-06-16 Next Science IP Holdings Pty Ltd Sólido antimicrobiano e métodos de fazer e usar o mesmo
CN112516087B (zh) * 2020-12-24 2023-03-24 四川普锐特药业有限公司 布地奈德鼻喷剂及其制备方法

Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3983233A (en) * 1972-05-19 1976-09-28 Ab Bofors Compositions and method of treating with stereoisomeric mixtures of 2-unsymmetrical 16,17-methylenedioxy steroids
WO1992011280A1 (fr) * 1990-12-20 1992-07-09 Instytut Farmaceutyczny Procede de preparation du stereoisomere (22r) de budesonide
WO1993011773A1 (fr) * 1991-12-18 1993-06-24 Aktiebolaget Astra Nouvelle combinaison de formoterol et de budesonide
GB2269992A (en) * 1992-08-14 1994-03-02 Rh Ne Poulenc Rorer Limited Powder inhalation formulations
WO1997001341A1 (fr) * 1995-06-29 1997-01-16 Mcneil-Ppc, Inc. Combinaison d'agents de stabilisation de mastocytes nasaux topiques avec des steroides nasaux topiques
EP0780127A1 (fr) * 1995-12-19 1997-06-25 The Procter & Gamble Company Pulvérisateur nasale contenant un stéréoide et un antihistamine
WO1997046243A1 (fr) * 1996-06-04 1997-12-11 The Procter & Gamble Company Aerosol nasal contenant un steroide intranasal et un antihistaminique

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3992534A (en) * 1972-05-19 1976-11-16 Ab Bofors Compositions and method of treating with component B of stereoisomeric mixtures of 2'-unsymmetrical 16,17-methylenedioxy steriods
US5509404A (en) 1994-07-11 1996-04-23 Aradigm Corporation Intrapulmonary drug delivery within therapeutically relevant inspiratory flow/volume values
AU6392496A (en) 1995-06-29 1997-01-30 Mcneil-Ppc, Inc. The combination of topical nasal antihistamines and topical nasal steroids
FR2756739B1 (fr) * 1996-12-05 2000-04-28 Astra Ab Nouvelle formulation de budesonide
SE9604486D0 (sv) * 1996-12-05 1996-12-05 Astra Ab Novel formulation

Patent Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3983233A (en) * 1972-05-19 1976-09-28 Ab Bofors Compositions and method of treating with stereoisomeric mixtures of 2-unsymmetrical 16,17-methylenedioxy steroids
WO1992011280A1 (fr) * 1990-12-20 1992-07-09 Instytut Farmaceutyczny Procede de preparation du stereoisomere (22r) de budesonide
WO1993011773A1 (fr) * 1991-12-18 1993-06-24 Aktiebolaget Astra Nouvelle combinaison de formoterol et de budesonide
GB2269992A (en) * 1992-08-14 1994-03-02 Rh Ne Poulenc Rorer Limited Powder inhalation formulations
WO1997001341A1 (fr) * 1995-06-29 1997-01-16 Mcneil-Ppc, Inc. Combinaison d'agents de stabilisation de mastocytes nasaux topiques avec des steroides nasaux topiques
EP0780127A1 (fr) * 1995-12-19 1997-06-25 The Procter & Gamble Company Pulvérisateur nasale contenant un stéréoide et un antihistamine
WO1997046243A1 (fr) * 1996-06-04 1997-12-11 The Procter & Gamble Company Aerosol nasal contenant un steroide intranasal et un antihistaminique

Also Published As

Publication number Publication date
IL125534A (en) 2003-06-24
GR1003011B (el) 1998-11-20
US20020016315A1 (en) 2002-02-07
AU5421198A (en) 1998-06-29
IL125534A0 (en) 1999-04-11
WO1998024450A1 (fr) 1998-06-11
CZ295792B6 (cs) 2005-11-16
EP0907365B1 (fr) 2003-05-07
ES2133130A1 (es) 1999-08-16
NL1007706A1 (nl) 1998-06-08
BE1011394A5 (fr) 1999-08-03
US20040101486A1 (en) 2004-05-27
DE69738000D1 (de) 2007-09-20
AU726515B2 (en) 2000-11-09
DE69721766D1 (de) 2003-06-12
FR2756739A1 (fr) 1998-06-12
HUP0000575A3 (en) 2001-03-28
DK0907365T3 (da) 2003-08-04
US6686346B2 (en) 2004-02-03
GR970100477A (el) 1998-08-31
PT907365E (pt) 2003-09-30
HUP0000575A2 (hu) 2000-10-28
ES2133130B1 (es) 2000-03-01
TR199801501T1 (xx) 1999-02-22
HK1020522A1 (en) 2000-05-12
DE69738000T2 (de) 2008-04-17
DE69721766T2 (de) 2004-03-04
US6986904B2 (en) 2006-01-17
JP2000508675A (ja) 2000-07-11
IE970854A1 (en) 1998-10-07
ATE369118T1 (de) 2007-08-15
EP0907365A1 (fr) 1999-04-14
CZ243798A3 (cs) 1998-11-11
CN1210467A (zh) 1999-03-10
FR2756739B1 (fr) 2000-04-28
CN1168450C (zh) 2004-09-29
NO983555L (no) 1998-08-03
ATE239482T1 (de) 2003-05-15
NZ330925A (en) 2000-05-26
NO983555D0 (no) 1998-08-03

Similar Documents

Publication Publication Date Title
NL1007706C2 (nl) Nieuwe formulering.
US6291445B1 (en) Low dose budesonide formulations and uses thereof
AU2020203081B2 (en) Liquid inhalation formulation comprising RPL554
US20180228857A1 (en) A nasal composition
US20220265549A1 (en) Pharmaceutical composition comprising ensifentrine
KR20200049697A (ko) 인 시추 겔-형성 약제학적 조성물 및 부비동 질병에 있어서 이의 용도
AU2005276345A1 (en) Use of a fatty acid for preparing a topical composition for allaying inflammatory reactions due to venemous hymenoptera stings
US20240108617A1 (en) An inhalable dry powder composition for pulmonary diseases
SA90110074B1 (ar) تركيبات صيدلانية متضمنة على محلول مائي من مشتق بيرانوكوينولين pyranoquinoline
US20220339099A1 (en) Compositions of interleukin-1 receptor antagonist
KR20070017170A (ko) 호흡기 질환의 치료

Legal Events

Date Code Title Description
AD1A A request for search or an international type search has been filed
RD2N Patents in respect of which a decision has been taken or a report has been made (novelty report)

Effective date: 19980721

PD2B A search report has been drawn up
V1 Lapsed because of non-payment of the annual fee

Effective date: 20100701